A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects

• Main Authors: Mikolaj Matloka (Author), Sylwia Janowska (Author), Piotr Pankiewicz (Author), Sofiya Kokhanovska (Author), Tomasz Kos (Author), Małgorzata Hołuj (Author), Izabela Rutkowska-Wlodarczyk (Author), Krzysztof Abramski (Author), Monika Janicka (Author), Piotr Jakubowski (Author), Maciej Świątkiewicz (Author), Marlena Welniak-Kaminska (Author), Joanna Hucz-Kalitowska (Author), Paulina Dera (Author), Lukasz Bojarski (Author), Paweł Grieb (Author), Piotr Popik (Author), Maciej Wieczorek (Author), Jerzy Pieczykolan (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Phosphodiesterase 10A (PDE10A) is expressed almost exclusively in the striatum and its inhibition is suggested to offer potential treatment in disorders associated with basal ganglia. We evaluated the selectivity, cytotoxicity, genotoxicity, pharmacokinetics and potential adverse effects...